Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06068673
Other study ID # Clindamycin in neurosurgery
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2023
Est. completion date December 30, 2023

Study information

Verified date January 2024
Source Damanhour University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A prospective, open-label, single center, controlled trial. 44 patients that underwent neurosurgery or presented meningitis signs, for whom Clindamycin add-on therapy to assess its effect on neurological complication in relation to Neuron-specific enolase (NSE) and Neurotensin biomarkers levels.


Description:

1. This is a prospective, open-label, single center, controlled trial. 44 patients that underwent neurosurgery or presented meningitis signs, for whom Clindamycin add-on therapy is prescribed (900 - 1200 mg twice daily) will be recruited from Alexandria University Main Hospital. 2. Whole blood samples will be collected for Analyses of Neuron-specific enolase (NSE) and Neurotensin will be detected by ELISA. 3. All patients will be assessed for complete blood count (CBC), kidney function, liver function, Methodology - Patients will be enrolled if they underwent surgery or presented with clinical signs of meningitis. - All enrolled 44 patients will be divided into two groups; Group I are patients who will receive clindamycin added-on therapy. Group II patients will be managed with the standard regimen. - Complete physical, laboratory, and radiological assessment will be done for all patients - All patients will be followed up during 2 weeks period. - Serum samples will be collected for measuring the biomarkers.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date December 30, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion criteria 1) Adult patients will be enrolled if they underwent neurosurgery or presented with clinical signs of meningitis. Exclusion criteria 1. Age lower than 18. 2. Females with a positive pregnancy test. 3. Known congestive heart failure or ischemic heart disease. 4. Any injury that disturbs the examination (high cervical cord injury or locked-in syndrome, could be a source of bias). 5. Severe brain disease (For example CVA history or brain tumor). 6. Renal failure with GFR lower than 60 ml/min. 7. Patients with unknown identity.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Clindamycin 600 mg
Clindamycin 900 - 1200 mg TWICE per day during 2 weeks period.
standard regimen
standard regimen

Locations

Country Name City State
Egypt Alexandria University Hospital Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Damanhour University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neuron-specific enolase (NSE) Blood Concentration Serum Level of NSE pg/ml 2 weeks
Primary Neurotensin Blood Concentration Serum Level of Neurotensin pg/ml 2 Weeks
See also
  Status Clinical Trial Phase
Completed NCT03682198 - Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions N/A
Withdrawn NCT00925093 - Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection Phase 1
Completed NCT05264012 - Incidence, Risk Factors and Impact of Significant Pain in Patients Undergoing Neurosurgery
Recruiting NCT05397574 - Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas
Completed NCT04153396 - Preemptive Infiltration With Betamethasone and Ropivacaine for Postoperative Pain in Laminoplasty or Laminectomy Phase 4
Recruiting NCT03087981 - Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition N/A
Completed NCT01513213 - Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient N/A
Recruiting NCT04034836 - Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain Phase 4
Completed NCT03532256 - Post-op Crowd Sourcing Health Data Via Text-messaging
Completed NCT05108337 - Superficial Cervical Plexus Block for Postoperative Chronic Pain N/A
Completed NCT02987816 - Neurosurgical Skill Enhancement Using Transcranial Stimulation N/A
Completed NCT03193905 - Preventing Inadvertent Hypothermia in Patients Undergoing Major Spinal Surgery N/A
Completed NCT00122096 - Perioperative Inflammation and Cyclooxygenase 2 (COX-2) Phase 4
Recruiting NCT05874050 - Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
Completed NCT01122537 - Characterization and Differential Diagnosis of Postneurosurgical Meningitis N/A
Recruiting NCT05294185 - Intra-operative Hyperspectral Imaging in Neurosurgery
Completed NCT04142203 - Implementation of 23 Hour Surgery Model in a Tertiary Hospital
Completed NCT05169281 - Distribution of Medication Disposal Packets - Acute Opioid Prescribing N/A
Recruiting NCT06264037 - The Experience in Neurorehabilitation Setting: a Qualitative Study
Recruiting NCT05860790 - Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery